France’s Novacap To Acquire Uetikon | Chemical & Engineering News
Volume 93 Issue 20 | p. 17 | Concentrates
Issue Date: May 18, 2015

France’s Novacap To Acquire Uetikon

Department: Business
Keywords: active pharmaceutical ingredients, acquisition, API
[+]Enlarge
Uetikon added this 250-L reactor (portion shown) to its kilo lab last year.
Credit: Uetikon
Uetikon added this 250-L reactor to its kilolab last year.
 
Uetikon added this 250-L reactor (portion shown) to its kilo lab last year.
Credit: Uetikon

Novacap, a French specialty and pharmaceutical chemicals company, will acquire CU Chemie Uetikon, which provides custom synthesis of drug intermediates and active pharmaceutical ingredients from a plant in Lahr, Germany. The company, with 135 employees, had sales of $45 million last year. “The acquisition of Uetikon fits perfectly into our strategy to reinforce our position in pharmaceuticals and health markets,” says Novacap CEO Pierre Luzeau. Novacap was formed in 2003 through the acquisition of a Rhodia business.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment